With the advent of digital therapeutics (DTx), development software as a medical device (SaMD) for mobile and wearable devices has gained significant attention in recent years. Existing DTx evaluations, such randomized clinical trials, mostly focus on verifying effectiveness products. To acquire deeper understanding engagement behavioral adherence, beyond efficacy, large amount contextual inter...